Tonix Pharmaceuticals Holding Corp at SNN Network Virtual Conference Transcript
Greetings, and welcome to the Tonix Pharmaceuticals Conference. It is now my pleasure to introduce your host, Dr. Seth Lederman, CEO of Tonix pharmaceuticals. Thank you, Dr. Lederman. You may begin.
Thank you. It's exciting to be presenting Tonix to you on this digital format. We have a big group. I'm going to answer questions at the end. So, there is a Q&A system and please use it. I try to leave five minutes at the end to answer questions.
So, Tonix is a public company on NASDAQ. So, I have to take you through our standard disclaimer on the next slide. I'll be making forward-looking statements. And our SEC documents are more complete, and we soon will have our 10-Q to update financial information about the company.
Tonix is a biopharmaceutical company. We are working on important problems. We are clinical stage. We focus on small molecules and biologics. And there are two main areas, CNS or central nervous system and immunology.
In
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
